Valuation: Omnicell, Inc.

Market Cap 1.86B 1.64B 1.52B 1.4B 2.63B 180B 2.67B 18.09B 7.07B 88.28B 7B 6.85B 305B P/E 2026 *
52.6x
P/E 2027 * 41.5x
Enterprise Value 1.86B 1.64B 1.52B 1.4B 2.63B 180B 2.67B 18.09B 7.07B 88.28B 7B 6.85B 305B EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.42x
Free-Float
76.27%
Yield 2026 *
-
Yield 2027 * -
1 day+2.86%
1 week-10.62%
Current month-1.25%
1 month+3.72%
3 months+9.71%
6 months-18.49%
Current year-9.49%
1 week 39.13
Extreme 39.1301
45.97
1 month 39.13
Extreme 39.1301
48.06
Current year 31.75
Extreme 31.75
55
1 year 28.09
Extreme 28.09
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/6/26 Free

Director

5,027 0.0111%
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%-10.62%+45.03%-34.46% 1.86B
+3.71%-4.68%-35.87%-4.93% 30.25B
-1.42%-14.59%-50.19%+138.93% 11.68B
+1.76%-3.42%-28.24%+56.17% 5.28B
-1.99%-3.05% - - 2.08B
-3.11%-1.18% - - 1.72B
-3.12%-3.55%-39.57% - 1.03B
-2.01%-3.95%+36.02%+105.63% 865M
-4.53%-4.82%-45.89%-58.09% 723M
+0.77%-12.33%+459.57%+721.88% 680M
Average -0.71%-6.28%+42.61%+132.16% 5.62B
Weighted average by Cap. +1.66%-6.72%-28.00%+43.73%

Financials

2026 *2027 *
Net sales 1.25B 1.1B 1.02B 935M 1.76B 120B 1.78B 12.1B 4.73B 59.05B 4.68B 4.58B 204B 1.32B 1.16B 1.07B 986M 1.85B 127B 1.88B 12.76B 4.98B 62.27B 4.94B 4.83B 215B
Net income 35.72M 31.37M 29.17M 26.77M 50.3M 3.44B 51.07M 346M 135M 1.69B 134M 131M 5.85B 45.83M 40.25M 37.43M 34.35M 64.54M 4.41B 65.53M 444M 174M 2.17B 172M 168M 7.5B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
24/07/26 US$41.00 +2.86% 567,479
23/07/26 US$39.86 -2.45% 729,974
22/07/26 US$40.86 -2.32% 647,007
21/07/26 US$41.83 -7.50% 1,579,679
20/07/26 US$45.22 -1.42% 554,164
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
41.00USD
Average target price
61.29USD
Spread / Average Target
+49.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock